An exploratory study of nimotuzumab combined with toripalimab and chemotherapy for locally advanced tonsillar cancer.
Saved in:
| Title: | An exploratory study of nimotuzumab combined with toripalimab and chemotherapy for locally advanced tonsillar cancer. |
|---|---|
| Authors: | Shi J; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., Wang Z; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.; School of Medicine, Northwest University, Xi'an, Shaanxi, China., Zhao Q; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., Liu P; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., Liang L; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., Chen G; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., He D; Department of Radiation Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China., Zhao D; Department of Otolaryngology-Head and Neck Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jul 14; Vol. 17, pp. 1890647. Date of Electronic Publication: 2026 Jul 14 (Print Publication: 2026). |
| Publication Type: | Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
